CANDEL THERAPEUTICS, INC. Capital Expenditures
CANDEL THERAPEUTICS, INC. (CADL) reported Capital Expenditures of $744.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13
- CANDEL THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $69.00K, a 122.58% increase year-over-year.
- CANDEL THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $675.00K, a 22400.00% increase year-over-year.
- CANDEL THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $409.00K, a 13533.33% increase year-over-year.
- CANDEL THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $144.00K.
- CANDEL THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $587.00K, a 3568.75% increase from fiscal 2024.
- CANDEL THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $16.00K, a 96.50% decline from fiscal 2023.
- CANDEL THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $457.00K, a 64.76% decline from fiscal 2022.
- CANDEL THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $1.30M, a 29.32% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $69.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $744.00K 10-Q · filed 2026-08-13 | $1.15M derived: sum of 3 quarters · filed 2026-08-13 | $1.30M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $675.00K 10-Q · filed 2026-05-14 | $1.08M derived: sum of 2 quarters · filed 2026-05-14 | $1.23M derived: sum of 3 quarters · filed 2026-05-14 | $1.26M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $409.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $553.00K derived: sum of 2 quarters · filed 2026-03-12 | $584.00K derived: sum of 3 quarters · filed 2026-08-13 | $587.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $144.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $175.00K derived: sum of 2 quarters · filed 2026-08-13 | $178.00K 10-Q · filed 2025-11-13 | $181.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $34.00K 10-Q · filed 2026-08-13 | $37.00K derived: sum of 3 quarters · filed 2026-08-13 | $37.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $3.00K 10-Q · filed 2026-05-14 | $6.00K derived: sum of 2 quarters · filed 2026-05-14 | $6.00K derived: sum of 3 quarters · filed 2026-05-14 | $12.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $3.00K derived: sum of 2 quarters · filed 2026-03-12 | $9.00K derived: sum of 3 quarters · filed 2026-03-12 | $16.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $6.00K derived: sum of 2 quarters · filed 2025-11-13 | $13.00K 10-Q · filed 2025-11-13 | $60.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $13.00K 10-Q · filed 2025-08-14 | $60.00K derived: sum of 3 quarters · filed 2025-08-14 | $163.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $7.00K 10-Q · filed 2025-05-13 | $54.00K derived: sum of 2 quarters · filed 2025-05-13 | $157.00K derived: sum of 3 quarters · filed 2025-05-13 | $326.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $150.00K derived: sum of 2 quarters · filed 2025-03-13 | $319.00K derived: sum of 3 quarters · filed 2025-03-13 | $457.00K 10-K · filed 2025-03-13 |
| 2023-09-30 | $103.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $272.00K derived: sum of 2 quarters · filed 2024-11-14 | $410.00K 10-Q · filed 2024-11-14 | $686.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $169.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $307.00K 10-Q · filed 2024-08-13 | $583.00K derived: sum of 3 quarters · filed 2024-08-13 | $798.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $138.00K 10-Q · filed 2024-05-14 | $414.00K derived: sum of 2 quarters · filed 2024-05-14 | $629.00K derived: sum of 3 quarters · filed 2024-05-14 | $1.26M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $276.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $491.00K derived: sum of 2 quarters · filed 2024-03-28 | $1.13M derived: sum of 3 quarters · filed 2024-03-28 | $1.30M 10-K · filed 2024-03-28 |
| 2022-09-30 | $215.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $850.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.02M 10-Q · filed 2023-11-09 | $1.52M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $635.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $806.00K 10-Q · filed 2023-08-10 | $1.31M derived: sum of 3 quarters · filed 2023-08-10 | $1.70M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $171.00K 10-Q · filed 2023-05-11 | $675.00K derived: sum of 2 quarters · filed 2023-05-11 | $1.07M derived: sum of 3 quarters · filed 2023-05-11 | $1.78M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $504.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $896.00K derived: sum of 2 quarters · filed 2023-03-30 | $1.61M derived: sum of 3 quarters · filed 2023-03-30 | $1.83M 10-K · filed 2023-03-30 |
| 2021-09-30 | $392.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.10M derived: sum of 2 quarters · filed 2022-11-10 | $1.33M 10-Q · filed 2022-11-10 | $1.78M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $710.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $939.00K 10-Q · filed 2022-08-05 | $1.39M derived: sum of 3 quarters · filed 2022-08-05 | $2.12M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | $229.00K 10-Q · filed 2022-05-12 | $682.00K derived: sum of 2 quarters · filed 2022-05-12 | $1.41M derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $453.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $1.18M derived: sum of 2 quarters · filed 2022-03-29 | $1.48M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $726.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.02M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $297.00K 10-Q · filed 2021-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |